mRNA Therapeutics: You’re Simply the Best, Better Than All the Rest
Wednesday, May 29, 2024 02:15 PM - 03:15 PM
Room 201
Tools & Tech
Roundtable
Organized by: ISCT 2024 Roundtable Committee
Moderator
Key Learning Objectives
1. Providing a cursory summary of the industry and some of the key advances in recent years
2. What is next in line therapeutically? Where is the science taking us and where are the limits?
3. Why mRNA is better than the rest?
4. How are mRNA therapeutics manufactured and how are manufacturing challenges hoped to be overcome?
Moderator
- Gad Berdugo, MS Eng, MBA, Explorium Capital LLC, United States
- Gary Pigeau, PhD, Cytiva, Canada
- Haig Aghajanian, PhD, Capstan Therapeutics, United States
- Tom Madden, PhD, Acuitas Therapeutics, Canada
Key Learning Objectives
1. Providing a cursory summary of the industry and some of the key advances in recent years
2. What is next in line therapeutically? Where is the science taking us and where are the limits?
3. Why mRNA is better than the rest?
4. How are mRNA therapeutics manufactured and how are manufacturing challenges hoped to be overcome?
